Five promising approaches to expand the depression armory

The paucity of candidates in the pipeline for the treatment of depression has been causing concern for some time. However, recent Datamonitor Healthcare analysis has identified five approaches to treating depression, all still at a relatively early stage of investigation, that could revitalize the field in coming years:

Glutamate is known to be important in regulating a variety of mood disorders, and there is growing clinical evidence, led by ketamine studies in treatment-resistant depression, that modulating